Medindia

X

Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC

Wednesday, August 27, 2008 General News J E 4
Advertisement
CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leadingprovider in specialist chemistry services to the pharmaceutical andbiotechnology industry, and ChemPrintCo LLC (MILPITAS, CA, USA), a unique andcost-effective provider of products and systems for the biotechnologyindustry, today announce the launch of AssayReady4U(TM).

AssayReady4U(TM) is an online based storefront which allows drugdiscovery researchers the ability to search, design and select compounds froma live physical collection of screening compounds. Then, using additionaloptions, build their final assay by selecting the exact amount andconcentration required to perform their own unique experiments.

The final customer-selected compounds are cleanly and accuratelydispensed into SBS standard well plates of the customer's choosing usingChemPrintCo's sophisticated and proprietary hydro-acoustic technologies. EachAssayReady4U plate is sealed in an argon environment and then vacuum-sealedin a moisture barrier bag and placed inside a temperature-controlled pack forshipment. All orders are shipped from stock within 24 hours of completionusing a commercial carrier. Upon receipt, the customer adds an appropriateamount of solvent to reach the desired test concentration.

Peakdale's collection is fundamentally rich in novel, GPCR-targetedcompounds. All compounds in the collection are selected for theirapplicability to GPCR research. Well-recognized ligand features are combinedwith proprietary scaffolds and monomers to produce a set of screeningcompounds for GPCR hit discovery.

Glenn Killingworth, Director of Business Development at Peakdale said: "Iam excited that we have built this collaboration in order to reach thesmaller drug-research groups who don't want to build assets to store, handleand plate compounds, but just want to receive ready-to-screen assays from ahigh quality collection, in exactly the format that they need to performtheir drug discovery work."

Peakdale's Director of Technology Paul Doyle said: "This represents anexciting new technology that allows a much broader base of researchers toaccess the world of diverse compounds in a cost effective manner."

Adding to this, ChemPrintCo's Vice President of Sales Ron Jones said:"The AssayReady4U(TM) products will be offered via an innovative web-basedone-stop shopping storefront. The researchers will effortlessly selectcompounds, assay test concentration, plate format, plate manufacturer andcontrols with a few clicks of a mouse thus optimizing their valuable time forresearch."

About Peakdale Molecular

Peakdale Molecular was founded in 1992. Today the company's customersinclude the majority of the major global pharmaceutical businesses and arapidly growing base of biotechnology companies worldwide. Peakdale's teamsof chemists combine experience in pharmaceutical R&D, medicinal chemistry,parallel synthesis, process development and fine chemicals to deliver uniquechemistry solutions to a range of drug discovery challenges. Peakdale hasgrowing capabilities in computational chemistry, analytical chemistry andADME screening.

The application of less commonly used chemistry, including hightemperature/pressure reactions, proprietary heterocyclic chemistry andnucleoside synthesis, enables Peakdale's chemists to generate uniquecompounds for drug discovery. Peakdale operates in several distinct marketsproviding novel screening compounds, targeted screening libraries, catalogueintermediates, custom synthesis and contract research. Further informationabout the company can be obtained at http://www.peakdale.com

About ChemPrintCo LLC

ChemPrintCo is a privately held company located in the heart of SiliconValley and the Bay Area's deep biotech and pharmaceutical community. Themanagement team has been together for over
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ATS Medical to Participate at the 2008 Thomas Weis...
S
PR Newswire Broadcast Minute for Wednesday, August...